Priyanshu Upadhyay,
- Student, Department of Pharmacy, P.K.University, Shivpuri, Madhya Pradesh, India
Abstract
The emergence of zoonotic viruses poses a significant threat to global public health, necessitating rapid advancements in vaccine development. This review highlights the current trends and innovative strategies employed in the creation of vaccines against zoonotic pathogens, including but not limited to viruses responsible for diseases such as Ebola, Zika, Nipah, and more recently, SARS-CoV-2. We discuss various vaccine platforms, including inactivated, live attenuated, mRNA, and viral vector vaccines, focusing on their effectiveness, safety profiles, and deployment challenges. The review also addresses the complexities associated with vaccine development, such as the need for rapid responses to outbreaks, the role of preclinical studies, and the importance of international collaboration. Zoonotic viruses, responsible for numerous recent epidemics, highlight the critical necessity of proactive and pre-emptive approaches in vaccine research, development, and distribution. Furthermore, we examine innovative approaches like nanoparticle delivery systems and recombinant vaccines that have emerged in response to evolving zoonotic threats. The findings underscore the importance of a multidisciplinary approach to vaccine development, integrating technological advancements, ecological surveillance, and public health initiatives to combat zoonotic diseases effectively.
Keywords: Zoonotic viruses, vaccine development, public health, mrna vaccines, viral vector vaccines, nanoparticle delivery systems, disease outbreaks, global health collaboration, innovations in immunization, vaccine platforms
[This article belongs to International Journal of Virus Studies ]
Priyanshu Upadhyay. Review of Current Trends in Vaccine Development against Zoonotic Viruses: Challenges and Innovations. International Journal of Virus Studies. 2024; 01(02):1-11.
Priyanshu Upadhyay. Review of Current Trends in Vaccine Development against Zoonotic Viruses: Challenges and Innovations. International Journal of Virus Studies. 2024; 01(02):1-11. Available from: https://journals.stmjournals.com/ijvs/article=2024/view=182509
References
- Pal M, Tariku F, Upadhyay D, Zende R. Current Innovations in the Diagnosis and Immunization of Emerging and Re-Emerging Zoonoses. Am. J. Epidemiol. 2024;12(2):23-8.
- Ahmed A, Safdar M, Sardar S, Yousaf S, Farooq F, Raza A, Shahid M, Malik K, Afzal S. Modern vaccine strategies for emerging zoonotic viruses. Expert Review of Vaccines. 2022 Dec 2;21(12):1711-25.
- Gao Q, Bao L, Mao H, Wang L, Xu K, Yang M, Li Y, Zhu L, Wang N, Lv Z, Gao H. Development of an inactivated vaccine candidate for SARS-CoV-2. Science. 2020 Jul 3;369(6499):77-81.
- Vrba SM, Kirk NM, Brisse ME, Liang Y, Ly H. Development and applications of viral vectored vaccines to combat zoonotic and emerging public health threats. Vaccines. 2020 Nov 13;8(4):680.
- Carpenter A, Waltenburg MA, Hall A, Kile J, Killerby M, Knust B, Negron M, Nichols M, Wallace RM, Behravesh CB, McQuiston JH. Vaccine preventable zoonotic diseases: challenges and opportunities for public health progress. Vaccines. 2022 Jun 22;10(7):993.
- Eyal N, Lipsitch M, Smith PG. Human challenge studies to accelerate coronavirus vaccine licensure. The Journal of infectious diseases. 2020 May 11;221(11):1752-6.
- Kristensen D, Giersing B, Hickling J, Kazi F, Scarna T, Kahn AL, Hsu V, Gandrup-Marino K, Menozzi-Arnaud M. A global collaboration to advance vaccine product innovations–The Vaccine Innovation Prioritisation Strategy. Vaccine. 2021 Dec 3;39(49):7191-4.
- Ghattas M, Dwivedi G, Lavertu M, Alameh MG. Vaccine technologies and platforms for infectious diseases: Current progress, challenges, and opportunities. Vaccines. 2021 Dec 16;9(12):1490.
- Buchy P, Buisson Y, Cintra O, Dwyer DE, Nissen M, de Lejarazu RO, Petersen E. COVID-19 pandemic: lessons learned from more than a century of pandemics and current vaccine development for pandemic control. International Journal of Infectious Diseases. 2021 Nov 1;112:300-17.
- Hotez PJ, Batista C, Amor YB, Ergonul O, Figueroa JP, Gilbert S, Gursel M, Hassanain M, Kang G, Kaslow DC, Kim JH. Global public health security and justice for vaccines and therapeutics in the COVID-19 pandemic. EClinicalMedicine. 2021 Sep 1;39.
- Dai L, Zheng T, Xu K, Han Y, Xu L, Huang E, An Y, Cheng Y, Li S, Liu M, Yang M. A universal design of betacoronavirus vaccines against COVID-19, MERS, and SARS. Cell. 2020 Aug 6;182(3):722-33.
- Dong X, Soong L. Emerging and re-emerging zoonoses are major and global challenges for public health. Zoonoses. 2021 Jun 28;1(1).
- Khan A, Khan T, Ali S, Aftab S, Wang Y, Qiankun W, Khan M, Suleman M, Ali S, Heng W, Ali SS. SARS-CoV-2 new variants: Characteristic features and impact on the efficacy of different vaccines. Biomedicine & Pharmacotherapy. 2021 Nov 1;143:112176.
- Carlson CJ, Farrell MJ, Grange Z, Han BA, Mollentze N, Phelan AL, Rasmussen AL, Albery GF, Bett B, Brett-Major DM, Cohen LE. The future of zoonotic risk prediction. Philosophical Transactions of the Royal Society B. 2021 Nov 8;376(1837):20200358.
- Wang LF, Crameri G. Emerging zoonotic viral diseases. Rev Sci Tech. 2014 Aug 1;33(2):569-81.
- Krammer, F. (2020). SARS-CoV-2 vaccines in development. Nature, 586(7830), 516-527.
- Le T, Sun C, Chang J, Zhang G, Yin X. mRNA vaccine development for emerging animal and zoonotic diseases. Viruses. 2022 Feb 15;14(2):401.
- Graham BS. Rapid COVID-19 vaccine development. Science. 2020 May 29;368(6494):945-6.
- Arshad R, Sargazi S, Fatima I, Mobashar A, Rahdar A, Ajalli N, Kyzas GZ. Nanotechnology for therapy of zoonotic diseases: A comprehensive overview. ChemistrySelect. 2022 Jun 7;7(21):e202201271.
- Monrad JT, Sandbrink JB, Cherian NG. Promoting versatile vaccine development for emerging pandemics. npj Vaccines. 2021 Feb 11;6(1):26.
| Volume | 01 |
| Issue | 02 |
| Received | 27/09/2024 |
| Accepted | 15/10/2024 |
| Published | 12/11/2024 |
Login
PlumX Metrics